Bio-Rad Laboratories, Inc. (BIO)
366.16
+5.76
(+1.60%)
USD |
NYSE |
Oct 09, 16:00
366.14
-0.02
(-0.01%)
Pre-Market: 20:00
Bio-Rad Laboratories Free Cash Flow (Quarterly) : 66.70M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 66.70M |
| March 31, 2026 | 78.10M |
| December 31, 2025 | 119.10M |
| September 30, 2025 | 89.20M |
| June 30, 2025 | 70.80M |
| March 31, 2025 | 95.50M |
| December 31, 2024 | 81.26M |
| September 30, 2024 | 123.38M |
| June 30, 2024 | 55.36M |
| March 31, 2024 | 29.00M |
| December 31, 2023 | 38.80M |
| September 30, 2023 | -337.99M |
| June 30, 2023 | 441.21M |
| March 31, 2023 | 76.24M |
| December 31, 2022 | 1.285B |
| September 30, 2022 | -1.378B |
| June 30, 2022 | 369.35M |
| March 31, 2022 | 1.045B |
| December 31, 2021 | -970.22M |
| September 30, 2021 | 195.74M |
| June 30, 2021 | 131.24M |
| March 31, 2021 | 94.06M |
| December 31, 2020 | 1.036B |
| September 30, 2020 | -237.01M |
| June 30, 2020 | -191.59M |
| Date | Value |
|---|---|
| March 31, 2020 | -130.68M |
| December 31, 2019 | 138.20M |
| September 30, 2019 | 68.66M |
| June 30, 2019 | 133.19M |
| March 31, 2019 | 19.31M |
| December 31, 2018 | 51.14M |
| September 30, 2018 | 40.22M |
| June 30, 2018 | 51.15M |
| March 31, 2018 | 13.16M |
| December 31, 2017 | 43.29M |
| September 30, 2017 | 8.292M |
| June 30, 2017 | 32.96M |
| March 31, 2017 | -95.54M |
| December 31, 2016 | 49.88M |
| September 30, 2016 | 12.15M |
| June 30, 2016 | 45.58M |
| March 31, 2016 | -32.74M |
| December 31, 2015 | 7.968M |
| September 30, 2015 | 57.48M |
| June 30, 2015 | 6.33M |
| March 31, 2015 | 1.059M |
| December 31, 2014 | 0.615M |
| September 30, 2014 | 62.67M |
| June 30, 2014 | 42.92M |
| March 31, 2014 | 30.63M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 1.675B |
| Agilent Technologies, Inc. | 439.00M |
| Danaher Corp. | 1.265B |
| Illumina, Inc. | 159.00M |
| Revvity, Inc. | 180.87M |